Brain injury after proton therapy or carbon ion therapy for head-and-neck cancer and skull base tumors.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 19735866)

Published in Int J Radiat Oncol Biol Phys on October 01, 2009

Authors

Daisuke Miyawaki1, Masao Murakami, Yusuke Demizu, Ryohei Sasaki, Yasue Niwa, Kazuki Terashima, Hideki Nishimura, Yoshio Hishikawa, Kazuro Sugimura

Author Affiliations

1: Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Hyogo, Japan. miyawaki@med.kobe-u.ac.jp

Articles by these authors

Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell (2006) 10.10

Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci U S A (2013) 2.76

Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol (2006) 2.68

Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys (2003) 2.34

Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J (2005) 2.25

Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. Am J Physiol Renal Physiol (2008) 2.24

Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents. Int J Urol (2012) 2.05

Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging (2010) 1.87

Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy. AJR Am J Roentgenol (2012) 1.75

CT-guided transthoracic needle aspiration biopsy of small (< or = 20 mm) solitary pulmonary nodules. AJR Am J Roentgenol (2003) 1.74

Differentiation of malignant and benign pulmonary nodules with quantitative first-pass 320-detector row perfusion CT versus FDG PET/CT. Radiology (2011) 1.72

Life-threatening cerebral edema caused by acute occlusion of a superior vena cava stent. Cardiovasc Intervent Radiol (2012) 1.70

Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology (2008) 1.69

Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer. AJR Am J Roentgenol (2008) 1.66

ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol (2006) 1.62

Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects. Eur Radiol (2008) 1.56

Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother Oncol (2004) 1.54

Update on positron emission tomography for imaging of prostate cancer. Int J Urol (2013) 1.53

Fragment c gamma receptor gene polymorphisms and breast cancer risk in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians. Breast Cancer Res Treat (2010) 1.53

Quantitative and qualitative assessments of lung destruction and pulmonary functional loss from reduced-dose thin-section CT in pulmonary emphysema patients. Acad Radiol (2009) 1.48

Curved nitinol stent-graft placement for treating blunt thoracic aortic injury: an early experience. Ann Thorac Surg (2008) 1.47

Prevalence of tuberculosis in small pulmonary nodules obtained by video-assisted thoracoscopic surgery. Respir Med (2005) 1.39

Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res (2005) 1.30

Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities. Int J Radiat Oncol Biol Phys (2010) 1.30

High-dose proton beam therapy for Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2006) 1.28

Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol (2003) 1.27

Hairy-related transcription factors inhibit GATA-dependent cardiac gene expression through a signal-responsive mechanism. J Biol Chem (2004) 1.24

Spectrum of FDG PET/CT findings of uterine tumors. AJR Am J Roentgenol (2010) 1.23

Preclinical biological assessment of proton and carbon ion beams at Hyogo Ion Beam Medical Center. Int J Radiat Oncol Biol Phys (2002) 1.21

Somatodendritic localization of the mRNA for EFA6A, a guanine nucleotide exchange protein for ARF6, in rat hippocampus and its involvement in dendritic formation. Eur J Neurosci (2004) 1.20

Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. Int J Radiat Oncol Biol Phys (2002) 1.20

Serum organochlorines and breast cancer risk in Japanese women: a case-control study. Cancer Causes Control (2008) 1.20

Angiosarcoma treated with radiotherapy: impact of tumor type and size on outcome. Int J Radiat Oncol Biol Phys (2002) 1.19

Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging (2009) 1.19

Usefulness of positron-emission tomographic images after proton therapy. Int J Radiat Oncol Biol Phys (2002) 1.18

Normal uptake of 18F-FDG in the testis: an assessment by PET/CT. Ann Nucl Med (2007) 1.16

MR angiography with sensitivity encoding (SENSE) for suspected pulmonary embolism: comparison with MDCT and ventilation-perfusion scintigraphy. AJR Am J Roentgenol (2004) 1.15

Global trends in hybrid imaging. Radiology (2010) 1.15

Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment. J Clin Invest (2015) 1.15

Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma. Cancer (2011) 1.13

Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: Preliminary experience in 40 subjects. J Magn Reson Imaging (2004) 1.13

Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT. Eur J Nucl Med Mol Imaging (2008) 1.12

MRI findings of uterine lipoleiomyoma correlated with pathologic findings. AJR Am J Roentgenol (2007) 1.11

Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus. Metabolism (2007) 1.11

High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio. Magn Reson Med Sci (2008) 1.10

T-type Ca2+ channel blockade prevents sudden death in mice with heart failure. Circulation (2009) 1.09

Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT. Eur J Nucl Med Mol Imaging (2008) 1.09

Contractile reserve, thallium-201 reverse redistribution and mismatch between perfusion and metabolism in reperfused infarct-related myocardium with delayed and incomplete functional recovery. Jpn Heart J (2004) 1.08

Tumor response to chemotherapy: the validity and reproducibility of RECIST guidelines in NSCLC patients. Cancer Sci (2003) 1.08

Extranodal Rosai-Dorfman disease: a solitary lesion with soft tissue reaction. Radiat Med (2005) 1.05

The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation. Int J Oncol (2010) 1.04

Developing an MR imaging strategy for diagnosis of ovarian masses. Radiographics (2006) 1.04

MR imaging of disorders associated with female infertility: use in diagnosis, treatment, and management. Radiographics (2003) 1.03

Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol (2013) 1.03

Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT. Eur J Nucl Med Mol Imaging (2008) 1.02

Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Japan. Nutr Cancer (2009) 1.02

A preliminary study of the T1rho values of normal knee cartilage using 3T-MRI. Eur J Radiol (2012) 1.02

Hrt and Hes negatively regulate Notch signaling through interactions with RBP-Jkappa. Biochem Biophys Res Commun (2006) 1.01

CT and MRI features of low-grade fibromyxoid sarcoma in the shoulder of a pediatric patient. Radiat Med (2006) 1.00

Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone. AJR Am J Roentgenol (2006) 1.00

Pseudoaneurysms of peroneal artery: treatment with transcatheter platinum coil embolization. Ann Thorac Cardiovasc Surg (2004) 1.00

MR imaging of diffuse adenomyosis changes after GnRH analog therapy. J Magn Reson Imaging (2002) 1.00

Anticoagulant-induced pseudothrombocytopenia occurring after transcatheter arterial embolization for hepatocellular carcinoma. Jpn J Clin Oncol (2006) 1.00

Dietary cadmium intake and breast cancer risk in Japanese women: a case-control study. Int J Hyg Environ Health (2013) 1.00

Adaptive iterative dose reduction using 3D processing for reduced- and low-dose pulmonary CT: comparison with standard-dose CT for image noise reduction and radiological findings. AJR Am J Roentgenol (2012) 0.99

Primary hepatic angiosarcoma on coregistered FDG PET and CT images. AJR Am J Roentgenol (2007) 0.99

Surgical spacer placement and proton radiotherapy for unresectable hepatocellular carcinoma. World J Gastroenterol (2010) 0.99

Potential preventive effects of follistatin-related protein/TSC-36 on joint destruction and antagonistic modulation of its autoantibodies in rheumatoid arthritis. Int Immunol (2003) 0.99

Dual-energy CT head bone and hard plaque removal for quantification of calcified carotid stenosis: utility and comparison with digital subtraction angiography. Eur Radiol (2009) 0.99

Feasibility of quantitative intrahepatic lipid imaging applied to the magnetic resonance dual gradient echo sequence. Magn Reson Med Sci (2003) 0.98

High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer. Cancer (2010) 0.98

Therapeutic effectiveness of diagnostic lymphangiography for refractory postoperative chylothorax and chylous ascites: correlation with radiologic findings and preceding medical treatment. AJR Am J Roentgenol (2013) 0.98

Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging. J Magn Reson Imaging (2010) 0.98

Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT. Eur J Nucl Med Mol Imaging (2009) 0.98

Primary pulmonary hypertension: 3D dynamic perfusion MRI for quantitative analysis of regional pulmonary perfusion. AJR Am J Roentgenol (2007) 0.97

Value of fusion of PET and MRI in the detection of intra-pelvic recurrence of gynecological tumor: comparison with 18F-FDG contrast-enhanced PET/CT and pelvic MRI. Ann Nucl Med (2013) 0.97

Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma. Int J Radiat Oncol Biol Phys (2006) 0.97

"Downgrading" of gastric varices with multiple collateral veins in balloon-occluded retrograde transvenous obliteration. J Vasc Interv Radiol (2005) 0.97

Usual and unusual MRI findings of ovarian fibroma: correlation with pathologic findings. Magn Reson Med Sci (2008) 0.96

Value of fusion of PET and MRI for staging of endometrial cancer: comparison with ¹⁸F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRI. Eur J Radiol (2013) 0.96

Particle beam radiotherapy with a surgical spacer placement for advanced abdominal leiomyosarcoma results in a significant clinical benefit. J Surg Oncol (2010) 0.96

Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy. Radiother Oncol (2005) 0.96

Value of retrospective image fusion of ¹⁸F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI. Eur J Radiol (2013) 0.96